Funder: Patient-Centered Outcomes Research Institute
Due Dates (Anticipated): September 2026 (Letter of Intent) | January 2027 (Full Application)
Funding Amounts: Up to $120 million total; individual projects: Category 1 ≤ $5M direct costs, Category 2/3 up to $12M direct costs; up to 5 years/project.
Summary: Supports high-impact, patient-centered comparative clinical effectiveness research, with emphasis on menopause, maternal sleep health, and ADRD mental health.
Key Information: This is a forecasted opportunity—dates are projected based on annual cycles.